Skip to content

Press Release

Recall of western drug-tainted proprietary Chinese medicine

27 Sep 2011

The Department of Health (DH) today (September 27) orders a licensed proprietary Chinese medicines (pCm) importer cum wholesaler, Tachio Trading Company (Tachio), to recall its product, Gan Mao Qing Capsules (registration number: HKP-02662), from shelf after the Department's surveillance programme has detected trace amount of paracetamol, a western drug, in a sample of the product purchased from the market.

Gan Mao Qing Capsules is manufactured in the Mainland for the relief of common cold and flu symptoms. The incriminated batch 113004 was imported into Hong Kong for sale this May.

The contaminant, paracetamol, is a pharmaceutical product that has long been commonly used for its anti-pyretic and analgesic effects.

"Initial investigation by DH reveals that although Tachio was responsible for secondary packaging of the said product here, contamination was unlikely as the product was never exposed," a DH spokesman remarks.

"Given that in the Mainland, mixing of western and Chinese drug ingredients is not uncommon, although the amount involved here is only trace, both intentional addition or cross-contamination could be possibilities. In any case, the matter has been referred to our Mainland counterpart for their assessment and necessary follow-up," the spokesman deliberates.

While DH's target is at the incriminated batch, Tachio volunteers to recall all batches of the drug in order to avoid market confusion. It has already set up a hotline, 2363 6806, for related enquiries. DH will be monitoring the recall besides continuing with the investigation.

"We can confirm that DH has not received any report of adverse incidents in connection. However, contravention of Section 52(1) of the Public Health and Municipal Services Ordinance Cap. 132, selling any drug not of the nature, substance or quality demanded by the purchaser, might have occurred here. The maximum penalty involved is HK$10,000 and three months' imprisonment. We will work with the Department of Justice for prosecution consideration on completion of our investigation," the spokesman states.

"Members of the public who have used the product and are either unsure or feeling unwell should seek advice from their healthcare professionals," the spokesman advises.

The Department of Health today (September 27) ordered a licensed proprietary Chinese medicines importer and wholesaler, Tachio Trading Company, to recall its product Gan Mao Qing Capsules (registration number: HKP-02662).

27 September 2011